Publications

Showing 9 of 0 results

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Using large language models to extract PD-L1 testing details from electronic health records

  Cohen A, Waskom M, Adamson B, et al.

  • Real-world evidence
  • Publication summary
  • Publications
  • Machine learning

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Assessing the potential value of the Flatiron Health commercial mortality data combined with publicly available death data for non-oncology research

  Reynolds MW, Collins JM, Meadows E, et al.

  • Real-world evidence
  • Publication summary
  • Publications

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Evaluation of real-world response rate in clinical trial-aligned cohorts of patients with lung, colon and breast cancer using machine learning

  Zhang C, Krismer K, Wang X, et al.

  • Publication summary
  • Publications
  • Machine learning
  • Breast cancer
  • Colorectal cancer
  • Non-small cell lung cancer

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Performance assessment of a disease-agnostic treatment sequencing heuristic for deriving line of therapy in a real-world, rare, multi-tumor cohort across tumor mutational burden status

  Bouzit L, Burugupalli M, Snow T, et al.

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Oncology practice setting classification in the US: Considerations for real world evidence

  Meadows ES, Reynolds M, Collin J, et al.

  • Real-world evidence
  • Publication summary
  • Publications

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Racial and ethnic inequities in endometrial cancer survival from 2017 to 2022: Assessing the influence of social determinants of health

  Pittell H, Ryals CA, Mbah O, et al.

  • Publication summary
  • Publications
  • Health equity
  • Advanced endometrial cancer

• Poster presented at: ISPOR US 2024; May 5-8, 2024; Atlanta, GA

  April 2024

  Prevalence and incidence of ROS1 and NTRK rearrangements in real-world patients with advanced non-small cell lung cancer in the United States

  Ma X, Lu Y, Lee A, et al.

  • Publication summary
  • Publications
  • Non-small cell lung cancer

• NEJM Evidence

  March 2024

  Broadening eligibility criteria and diversity among patients for cancer clinical trials

  Kaur M, Frahm F, Lu Y, et al.

  • Clinical research
  • Publication summary
  • Publications
  • Health equity

• JCO Oncology Practice

  March 2024

  Racial and ethnic inequities at the practice and physician provider levels in timely NGS for patients with aNSCLC treated in the US community setting

  Vidal GA, Jain N, Fisher A, et al.

  • Publication summary
  • Publications
  • Health equity
  • Non-small cell lung cancer